title: [Should every patient with atrial fibrillation get anticoagulants?].
abstract: Embolic complications are very common in patients with atrial fibrillation. Patients over 60 years with organic heart disease, arterial hypertension, diabetes mellitus and previous embolic complications are prone to embolic complications. In these high risk groups anticoagulation should be introduced when no contraindications exist. Long term anticoagulation therapy should be evaluated for each patient individually balancing pro and contra. For patients with a low risk of embolism aspirin is a valuable alternative to anticoagulation. Patients below 60 years without heart disease and without additional risks do not need any therapy.
authors.affiliation: Departement für Innere Medizin, Universitätsspital Zürich.
authors.forename: J
authors.initials: J
authors.lastname: Turina
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D000075202:Contraindications; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
vernacular_title: Soll jeder Patient mit Vorhofflimmern antikoaguliert werden?